…also exhibits some type 3 phosphodiesterase inhibitor (PDEI) activity, which may contribute to its inotropic profile. The drug possesses an active, acetylated metabolite with a…

…short for routine use, but it may be considered in selected patients with a high bleeding risk. Shorter approaches should therefore be reserved for circumstances…

…in the hospital. Endocrine Society clinical practice guideline on the management of hyperglycaemia in hospitalised adults. The summary of product characteristics for each insulin preparation.

…guideline systems: Classification Fasting triglycerides Non fasting triglycerides Mild to moderate HTG 150–499 mg/dL (1.7–5.6 mmol/L) in some guidance…

…cerebrovascular disease. PA is associated with cardiac hypertrophy, myocardial fibrosis, diastolic dysfunction and heart failure. Compared with patients with primary hypertension matched for age, sex…

…Place in lipid lowering therapy General treatment sequence High intensity statin therapy remains the foundation of lipid lowering treatment for patients with chronic coronary syndrome…

…Adenosine is an endogenous nucleoside present throughout the body that interacts with G protein coupled A1 receptors located on the extracellular surface of cardiac cells…

…some form of statin therapy after systematic reassessment and rechallenge. The principal manifestation is statin associated muscle symptoms (SAMS). These range from diffuse myalgia with…

…owing to changes in intra and extracellular electrolyte concentrations. Some electrolyte imbalances are clinically negligible (from an electrophysiological standpoint), whereas others may be life threatening…

…the "healthy" range can still harbor significant metabolic risk. 3 For patients with a BMI below 35 kg/m², direct assessments such as waist circumference…